Table 1.
Median and interquartile range values of the number of spontaneous recurrent seizures (SRSs) in the various treatment groups with cannabidiol (CBD) at 12 mg/kg, 120 mg/kg, or with medium-chain triglyceride (MCT) oil, subdivided by stages (ST.), or considered altogether. Ten animals per group were included, except where a single outlier per group was identified and removed.
| Total Number of SRSs | |||
|---|---|---|---|
| Group | Pre-Treatment | Treatment | Outlier Removal |
| MCT OIL | 5.00 (2.75–11.50) | 8.00 (4.75–11.25) | no |
| CBD 12 | 2.00 (1.00–14.00) | 3.00 (1.00–7.00) | yes |
| CBD 120 | 5.00 (2.00–11.50) | 0.00 (0.00–2.50) | yes |
| Number of ST. 0–3 SRSs | |||
| MCT OIL | 0.00 (0.00–2.25) | 0.00 (0.00 – 2.25) | no |
| CBD 12 | 0.00 (0.00–0.00) | 0.00 (0.00–1.00) | yes |
| CBD 120 | 0.00 (0.00–0.00) | 0.00 (0.00–1.00) | yes |
| Number of ST. 4–5 SRSs | |||
| MCT OIL | 4.00 (2.75–7.00) | 6.50 (3.75–11.25) | no |
| CBD 12 | 2.00 (1.00–13.00) | 3.00 (1.00–4.50) | yes |
| CBD 120 | 5.00 (2.00–11.50) | 0.00 (0.00–2.50) | yes |